ACEA_ER_80hr
ATG_Ahr_CIS_up
ATG_AP_1_CIS_up
ATG_AP_2_CIS_up
ATG_BRE_CIS_up
ATG_C_EBP_CIS_up
ATG_CMV_CIS_up
ATG_CRE_CIS_up
ATG_DR4_LXR_CIS_up
ATG_DR5_CIS_up
ATG_E_Box_CIS_up
ATG_E2F_CIS_up
ATG_EGR_CIS_up
ATG_ERE_CIS_up
ATG_Ets_CIS_up
ATG_FoxA2_CIS_up
ATG_FoxO_CIS_up
ATG_GATA_CIS_up
ATG_GRE_CIS_up
ATG_HIF1a_CIS_up
ATG_HNF6_CIS_up
ATG_HSE_CIS_up
ATG_IR1_CIS_up
ATG_ISRE_CIS_up
ATG_M_19_CIS_up
ATG_M_32_CIS_up
ATG_MRE_CIS_up
ATG_Myb_CIS_up
ATG_Myc_CIS_up
ATG_NF_kB_CIS_up
ATG_NFI_CIS_up
ATG_NRF1_CIS_up
ATG_NRF2_ARE_CIS_up
ATG_Oct_MLP_CIS_up
ATG_p53_CIS_up
ATG_Pax6_CIS_up
ATG_PBREM_CIS_up
ATG_PPRE_CIS_up
ATG_PXRE_CIS_up
ATG_RORE_CIS_up
ATG_Sox_CIS_up
ATG_Sp1_CIS_up
ATG_SREBP_CIS_up
ATG_STAT3_CIS_up
ATG_TA_CIS_up
ATG_TAL_CIS_up
ATG_TGFb_CIS_up
ATG_VDRE_CIS_up
ATG_Xbp1_CIS_up
ATG_AR_TRANS_up
ATG_CAR_TRANS_up
ATG_ERa_TRANS_up
ATG_ERRg_TRANS_up
ATG_FXR_TRANS_up
ATG_GR_TRANS_up
ATG_HNF4a_TRANS_up
ATG_LXRa_TRANS_up
ATG_LXRb_TRANS_up
ATG_M_06_TRANS_up
ATG_M_19_TRANS_up
ATG_M_32_TRANS_up
ATG_M_61_TRANS_up
ATG_NURR1_TRANS_up
ATG_PPARa_TRANS_up
ATG_PPARd_TRANS_up
ATG_PPARg_TRANS_up
ATG_PXR_TRANS_up
ATG_RARa_TRANS_up
ATG_RARb_TRANS_up
ATG_RARg_TRANS_up
ATG_RORg_TRANS_up
ATG_RXRa_TRANS_up
ATG_RXRb_TRANS_up
ATG_THRa1_TRANS_up
ATG_VDR_TRANS_up
BSK_3C_Eselectin_up
BSK_3C_IL8_up
BSK_3C_MCP1_up
BSK_3C_Thrombomodulin_up
BSK_3C_TissueFactor_up
BSK_3C_uPAR_up
BSK_4H_Eotaxin3_up
BSK_4H_Pselectin_up
BSK_4H_uPAR_up
BSK_4H_VEGFRII_up
BSK_BE3C_HLADR_up
BSK_BE3C_IL1a_up
BSK_BE3C_MMP1_up
BSK_BE3C_PAI1_up
BSK_BE3C_tPA_up
BSK_BE3C_uPA_up
BSK_BE3C_uPAR_up
BSK_CASM3C_HLADR_up
BSK_CASM3C_IL6_up
BSK_CASM3C_IL8_up
BSK_CASM3C_LDLR_up
BSK_CASM3C_MCP1_up
BSK_CASM3C_MCSF_up
BSK_CASM3C_MIG_up
BSK_CASM3C_Proliferation_up
BSK_CASM3C_SAA_up
BSK_CASM3C_Thrombomodulin_up
BSK_CASM3C_TissueFactor_up
BSK_CASM3C_uPAR_up
BSK_CASM3C_VCAM1_up
BSK_hDFCGF_CollagenIII_up
BSK_hDFCGF_EGFR_up
BSK_hDFCGF_IP10_up
BSK_hDFCGF_MIG_up
BSK_hDFCGF_MMP1_up
BSK_hDFCGF_PAI1_up
BSK_hDFCGF_Proliferation_up
BSK_hDFCGF_SRB_up
BSK_hDFCGF_TIMP1_up
BSK_KF3CT_ICAM1_up
BSK_KF3CT_IL1a_up
BSK_KF3CT_IP10_up
BSK_KF3CT_MCP1_up
BSK_KF3CT_TIMP2_up
BSK_LPS_Eselectin_up
BSK_LPS_IL1a_up
BSK_LPS_IL8_up
BSK_LPS_MCP1_up
BSK_LPS_PGE2_up
BSK_LPS_TissueFactor_up
BSK_LPS_TNFa_up
BSK_SAg_CD38_up
BSK_SAg_Eselectin_up
BSK_SAg_IL8_up
BSK_SAg_MCP1_up
BSK_SAg_PBMCCytotoxicity_up
OT_AR_ARSRC1_0480
OT_AR_ARSRC1_0960
OT_ER_ERaERa_0480
OT_ER_ERaERa_1440
OT_ER_ERaERb_0480
OT_ER_ERaERb_1440
OT_ER_ERbERb_0480
OT_ER_ERbERb_1440
OT_ERa_EREGFP_0120
OT_ERa_EREGFP_0480
OT_FXR_FXRSRC1_0480
OT_FXR_FXRSRC1_1440
OT_NURR1_NURR1RXRa_0480
OT_NURR1_NURR1RXRa_1440
OT_PPARg_PPARgSRC1_0480
OT_PPARg_PPARgSRC1_1440
TOX21_AR_BLA_Agonist_ratio
TOX21_AR_BLA_Antagonist_ratio
TOX21_AR_BLA_Antagonist_viability
TOX21_AR_LUC_MDAKB2_Agonist
TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881
TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability
TOX21_Aromatase_Inhibition
TOX21_Aromatase_Inhibition_viability
TOX21_ELG1_LUC_Agonist
TOX21_ELG1_LUC_Agonist_viability
TOX21_ERa_BLA_Agonist_ratio
TOX21_ERa_BLA_Antagonist_ratio
TOX21_ERa_BLA_Antagonist_viability
TOX21_ERa_LUC_VM7_Agonist
TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2
TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2_viability
TOX21_GR_BLA_Agonist_ratio
TOX21_GR_BLA_Antagonist_ratio
TOX21_GR_BLA_Antagonist_viability
TOX21_MMP_fitc
TOX21_MMP_ratio_down
TOX21_MMP_rhodamine
TOX21_PPARg_BLA_Agonist_ratio
TOX21_TR_LUC_GH3_Antagonist
TOX21_TR_LUC_GH3_Antagonist_viability
TOX21_AhR_LUC_Agonist
TOX21_AhR_LUC_Agonist_viability
TOX21_ARE_BLA_agonist_ratio
TOX21_HSE_BLA_agonist_ratio
TOX21_p53_BLA_p1_ratio
TOX21_FXR_BLA_agonist_ratio
TOX21_FXR_BLA_antagonist_ratio
TOX21_FXR_BLA_antagonist_viability
TOX21_PPARd_BLA_agonist_ratio
TOX21_PPARd_BLA_antagonist_ratio
TOX21_PPARd_BLA_antagonist_viability
TOX21_PPARg_BLA_antagonist_ratio
TOX21_PPARg_BLA_antagonist_viability
TOX21_VDR_BLA_agonist_ratio
TOX21_VDR_BLA_antagonist_ratio
TOX21_VDR_BLA_antagonist_viability
TOX21_DT40
TOX21_ARE_BLA_agonist_viability
TOX21_HSE_BLA_agonist_viability
TOX21_p53_BLA_p1_viability
TOX21_FXR_BLA_agonist_viability
ATG_XTT_Cytotoxicity_up
TOX21_p53_BLA_p2_ratio
TOX21_p53_BLA_p2_viability
TOX21_p53_BLA_p3_ratio
TOX21_p53_BLA_p3_viability
TOX21_p53_BLA_p4_ratio
TOX21_p53_BLA_p4_viability
TOX21_p53_BLA_p5_ratio
TOX21_p53_BLA_p5_viability
TOX21_ESRE_BLA_ratio
TOX21_ESRE_BLA_viability
TOX21_NFkB_BLA_agonist_ratio
TOX21_NFkB_BLA_agonist_viability
TOX21_RAR_LUC_Agonist
TOX21_RAR_LUC_Agonist_viability
TOX21_RORg_LUC_CHO_Antagonist
TOX21_RORg_LUC_CHO_Antagonist_viability
TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881
TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881_viability
TOX21_RXR_BLA_Agonist_ratio
TOX21_RXR_BLA_Agonist_viability
TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide
TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability
TOX21_RAR_LUC_Antagonist
TOX21_RAR_LUC_Antagonist_viability
TOX21_H2AX_HTRF_CHO_Agonist_ratio
TOX21_AP1_BLA_Agonist_ratio
TOX21_AP1_BLA_Agonist_viability
TOX21_TSHR_HTRF_Agonist_ratio
TOX21_TSHR_HTRF_Antagonist_ratio
TOX21_TSHR_HTRF_wt_ratio
TOX21_CAR_Agonist
TOX21_CAR_Agonist_viabillity
TOX21_CAR_Antagonist
TOX21_CAR_Antagonist_viability
TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2
TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2_viability
TOX21_ERR_Agonist
TOX21_ERR_Antagonist
TOX21_HDAC_Inhibition
TOX21_HDAC_Inhibition_viability
TOX21_HRE_BLA_Agonist_ratio
TOX21_HRE_BLA_Agonist_viability
TOX21_PGC_ERR_Agonist
TOX21_PGC_ERR_Antagonist
TOX21_SHH_3T3_GLI3_Agonist
TOX21_SHH_3T3_GLI3_Agonist_viability
TOX21_SHH_3T3_GLI3_Antagonist
TOX21_SHH_3T3_GLI3_Antagonist_viability
TOX21_ERb_BLA_Antagonist_ratio
TOX21_ERb_BLA_Antagonist_viability
TOX21_ERb_BLA_Agonist_ratio
TOX21_ERb_BLA_Agonist_viability
TOX21_PR_BLA_Agonist_ratio
TOX21_PR_BLA_Agonist_viability
TOX21_PR_BLA_Antagonist_ratio
TOX21_PR_BLA_Antagonist_viability
TOX21_DT40_100
TOX21_DT40_657
TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780
TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability
TOX21_PXR_Agonist
TOX21_TRHR_HEK293_Agonist
TOX21_TRHR_HEK293_Antagonist
TOX21_CASP3_HEPG2
TOX21_CASP3_HEPG2_viability
TOX21_CASP3_CHO
TOX21_CASP3_CHO_viability
TOX21_SBE_BLA_Antagonist_ratio
TOX21_SBE_BLA_Antagonist_viability
TOX21_SBE_BLA_Agonist_ratio
TOX21_SBE_BLA_Agonist_viability
UPITT_HCI_U2OS_AR_TIF2_Nucleoli_Antagonist
UPITT_HCI_U2OS_AR_TIF2_Nucleoli_Agonist
UPITT_HCI_U2OS_AR_TIF2_Nucleoli_Cytoplasm_Ratio_Antagonist
UPITT_HCI_U2OS_AR_TIF2_Nucleoli_Cytoplasm_Ratio_Agonist
CCTE_Harrill_HTTr_Viability_MCF7_DMEM_6hr
CCTE_Harrill_HTTr_Apoptosis_MCF7_DMEM_6hr